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Abstract
Rabies remains endemic in many regions of Turkey. As a
consequence, humans are at risk of this fatal disease through
encounters with rabid animals. The present study describes four
recent cases of rabies in humans. Subsequent phylogenetic analy-
sis of the rabies virus isolates obtained from each case demon-
strates the distinct geographical distribution of rabies virus
variants within Turkey. The study suggests that rabies virus
translocation has occurred across Turkey and might be the
source of the emergence of a genetically similar variant in the
Golan Heights region on the Israeli/Syrian border in 2004.
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Rabies is one of the major zoonotic diseases in Turkey. The
virus is enzootic in many areas of Turkey, with dogs being
the principal reservoir and vector, bringing humans into
contact with the virus [1]. The presence of the disease in
dogs and, in some areas, in wildlife, represents a continuing
threat to public health and causes economic losses, especially
in domestic livestock [2]. Within Turkey, veterinary control
and research institutes are responsible for diagnosis of the
disease (in animals) at sites distributed throughout the coun-
try (Adana, Elazıg, Erzurum, Etlik-Central-Ankara, Konya,
Istanbul, Izmir, Samsun). The Ministry of Agriculture and
Rural Affairs reports to OIE and WHO regularly. Reported
cases in animals between 2002 and 2006 were 217, 156, 111,
193 and 210, respectively, suggesting the persistence of the
disease (http://www.who-rabies-bulletin.org). The Ministry of
Health is responsible for diagnosis of cases of rabies in
humans and for subsequent reporting to WHO.
In the present study, we have investigated four recent
cases of rabies in humans (Table 1). This is the ﬁrst report
of ante-mortem rabies diagnosis in Turkey; cases TR149 and
TR40 tested positive according to the direct ﬂuorescent
antibody test (dFAT) on corneal smears and RT-PCR on
saliva and eye swabs. It is also the ﬁrst genetic analysis of
rabies viruses of human origin from Turkey.
The ﬁrst case (TR33) occurred in Kilis province in 2002, the
second (TR149) in Agri province in 2004, the third (TR40) in
Adana province in 2006, and the fourth (TR3) in Aydin
province in 2006. For each case, brain tissue specimens, saliva,
corneal impressions, swabs from the eyes, and cerebrospinal
ﬂuid were collected. Samples were shipped to the National
Reference Laboratory for rabies at the Etlik Central Veterinary
Control and Research Institute (ECVCRI) for further investi-
gation. Infection with rabies was conﬁrmed by dFAT. The test
was performed using a commercial conjugate (Fujirebio, Mal-
vern, USA) as described previously [3]. The mouse inoculation
test was undertaken using standard protocols [4]. Total RNA
was extracted directly from samples by the TRIzol method
according to the manufacturer’s instructions (TRI Reagent;
Sigma-Aldrich ChemieGmbH, Germany). Heminested RT-PCR
was performed as described by Heaton et al. [5]. The products
of positive PCR ampliﬁcation were puriﬁed with a commercial
kit (QIAquick gel extraction KIT, QiagenGmbH, Germany)
and were sequenced using the BigDye Terminator v3.1 cycle
sequencing kit (Applied Biosystems, Foster City, CA, USA)
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according to the manufacturer’s instructions. Automated ﬂuo-
rescence sequencing was performed with an ABI PRISM 310
Genetic Analyzer (Applied Biosystems). The sequences were
edited using Bioedit software (http://www.mbio.ncsu.edu/
BioEdit/page2.html) and were aligned with the ClustalX1.83
program, version 8 [6]. Further sequences of rabies virus iso-
lates from Turkey (Fig. 1) and neighbouring countries in the
south were obtained from GenBank (Table 2). The phylo-
genetic tree was generated using Phylip, version 3.2, as previ-
ously described [7]. One thousand replicates were performed,
with values over 700 being considered signiﬁcant.
A 500 bp partial sequence of the nucleoprotein gene was
obtained from each isolate. Sequencing results of the positive
primary PCR ampliﬁcations conﬁrmed that all four rabies
virus isolates from humans were from genotype 1 and were
distinct from the ﬁxed Pasteur virus strain. Comparison with
a panel of rabies viruses indicated a strong geographical link-
age with endemic viruses in the various regions of Turkey.
Molecular epidemiology suggests that the rabies virus iso-
lates identiﬁed within Turkey are more related to isolates
from the Middle East than to those from Europe [8,9]. A
phylogenetic comparison of 37 rabies virus sequences exclu-
sively from Turkey (Fig. 1a) conﬁrms the geographical sepa-
ration of two groups within the country, namely from
eastern and western regions. This comparison conﬁrms pre-
vious observations [8].
A larger comparison of a representative panel of Turkish
isolates, including the four human virus isolate sequences,
with rabies virus sequences from neighbouring countries
throughout the Middle East (Table 1, Fig. 1b) suggests that
the viruses from western Turkey are distinct from the
viruses found in other countries including Israel, Jordan,
Lebanon, Saudi Arabia and Iran. The single representative of
the eastern Turkish lineage (T149) is found among the
Middle East variants, suggesting a common origin of these
viruses. As observed in previous studies, there appears to be
clustering between viruses from the Eastern Turkish lineage
and a rabies virus sequence from Georgia (RV308) to the
north-east (Fig. 1b) [8,10]. Furthermore, the small cluster of
viruses from southern Turkey, including two human cases, is
closely linked to a group of viruses that emerged in the
Golan Heights region in 2004. The longer sequence used for
this comparison (420 bp) appears to have considerably
improved the bootstrap support for this analysis.
Further analysis of these isolates with sequences derived
from rabies viruses from the Middle East region revealed that
they formed a tight cluster with a group of viruses recently iso-
lated from the Golan Heights region. David et al. [9] have
already documented the association between this genetic
variant and viruses from Turkey. Recent isolations of virus had
suggested the emergence of a new variant in northern Israel
[11]. This present study suggests that there is a link, possibly
associated with the translocation of rabies virus from a source
in Turkey, directly south, and emerging as a fresh epizootic in
the Golan Heights. These data provide preliminary evidence of
long distance translocation of a strain of dog rabies within the
Middle East. This rabies virus variant might have originated in
north-west Turkey where the western Turkish clade has been
endemic at least since 1989 (Fig. 1a) [8,12]. It then appeared in
southern Turkey, causing a human fatality in 2002 (TR33). A
later case in 2003 in a dog suggests that dogs were the reser-
voir rather than wildlife.
TABLE 1. Case reports of four cases of rabies in humans in Turkey between 2002 and 2006
Case no. Year Gender Province Case details
TR33 2002 Male Kilis A soldier was bitten by an unidentiﬁed animal during special duty at night in Kilis. He failed to inform a clinician and did
not receive speciﬁc anti-rabies prophylaxis. After an undeﬁned incubation period, he developed neurological disease
and died. Clinicians suspected rabies and a brain sample was sent to the Rabies Diagnosis Laboratory at Etlik Central
Veterinary Control and Research Institute (ECVCRI), Rabies Diagnosis Laboratory. Rabies was conﬁrmed by the
ﬂuorescent antibody test and the mouse inoculation test
TR149 2004 Male Agri Between 23 August and 3 September, a resident ofthe village of Kazancı (Patnos District) in the East Anatolian Region
was bitten on his arm and ﬁnger by a fox when hunting. He did not request speciﬁc anti-rabies treatment. Clinical signs
started 30–35 days later in the ﬁnal week of September. He was admitted to a number of governmental health units
and ﬁnally was sent to the Ministry of Health, Ankara Training and Research Hospital. Rabies was considered, because
of both clinical signs and history of an animal bite. Samples of saliva and cerebrospinal ﬂuid were sent to ECVCRI on 6
October and corneal impressions were sent on 7 October. Rabies was conﬁrmed on 7 October by hemi-nested
RT-PCR and by the ﬂuorescent antibody test on 8 October. The patient died on 8 October, approximately 40 days
following exposure
TR40 2006 Female Adana A villager was bitten by her dog in the spring but did not seek medical treatment and received no anti-rabies
prophylaxis. She developed clinical signs between 35 and 40 days in April and was taken to hospital by members of her
family. Rabies was considered, based on clinical presentation and history of a dog bite. Doctors informed ECVCRI and
sent saliva, cerebrospinal ﬂuid, corneal impressions and rheum from the eyes. Rabies was conﬁrmed by heminested
RT-PCR and the ﬂuorescent antibody test before death
TR3 2006 Male Aydin A villager developed clinical signs of rabies and he was transferred to a health unit in Aydin. He did not receive speciﬁc
anti-rabies prophylaxis. After several days, he died. Doctors suspected rabies, based on clinical presentation. Brain
tissue was sent to the local rabies diagnostic centre and rabies was conﬁrmed by the ﬂuorescent antibody test
and mouse inoculation test post-mortem. The source of the virus is unknown
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FIG. 1. Phylogenetic analysis of rabies virus
(RABV) nucleoprotein sequences derived from
four human cases in Turkey. (a) Phylogeny
(322 bp) derived from viruses isolated in
Turkey. The Pastuer virus (PV) and Challenge
Virus Standard (CVS) ﬁxed rabies isolates
were used as an outgroup. Bootstrap values
>700 were considered signiﬁcant and are
included in the ﬁgure. (b) Phylogeny of RABV
nucleoprotein sequences (420 bp) derived
from viruses isolated from throughout the
Middle East. Rabies virus sequences isolated
from humans are underlined. The Pastuer
virus (PV) was used as an outgroup and boot-
strap values greater than 700 are included.
Inset provides a map of the Middle East show-
ing the location of countries in close proximity
to Turkey. The location of the Golan Heights
area is highlighted (arrow) and the possible
direction of RABV spread is indicated by a
dashed line.
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In 2004, the ﬁrst case of rabies from this new lineage
was reported in the Golan Heights, leading to a sudden
increase in animal cases in 2005. Direct translocation of
the vector could have achieved the movement from Tur-
key to the Israel/Syria border. Rabies cases are reported
in both Syria and Lebanon, although the number of cases
is low [13], most probably as a result of poor surveillance.
At present, it is only possible to speculate on the mecha-
nism of movement, although the available phylogenetic evi-
dence suggests that translocation of a new variant of
rabies has occurred between Turkey and Israel in recent
years.
TABLE 2. Isolate details derived from rabies virus from Turkey and neighbouring countries between 1986 and 2006
Sample
number Country Province/location Host Year
Genebank
accession
number References
RV201 Turkey Yavuzeli Dog 1989 EU180613 This study
RV202 Turkey Samsun Dog 1989 AY091608 8
RV203 Turkey Samsun Wolf 1989 AY091609 8
T1/2000 Turkey Manisa Fox 2000 AY091610 8
T2/2001 Turkey Izmir Fox 2001 AY091611 8
T3/2001 Turkey Izmir Fox 2001 AY091612 8
T4/2001 Turkey Manisa Fox 2001 AY091613 8
T5/2001 Turkey Manisa Fox 2001 AY091614 8
T6/2001 Turkey Erzurum Fox 2001 AY091615 8
T8/2001 Turkey Erzurum Dog 2001 AY091616 8
T8/2001 Turkey Gaziantep Bovine 2001 AY091618 8
T9/2001 Turkey Mardin Cow 2001 AY091618 8
T10/2001 Turkey Ardahan Dog 2001 AY091619 8
T11/2001 Turkey Ardahan Dog 2001 AY091620 8
T13/2001 Turkey Bursa Dog 2001 AY091621 8
T14/2001 Turkey Bursa Dog 2001 AY091622 8
T18/2001 Turkey Istanbul Dog 2001 AY091623 8
T18/2001 Turkey Istanbul Dog 2001 AY091624 8
T20/2001 Turkey Istanbul Dog 2001 AY091625 8
T23/2003 Turkey Hatay Cow 2003 AY956352 2
T24/2003 Turkey Gaziantep Dog 2003 EU180614 This study
T27/2003 Turkey Istanbul Jackal 2003 AY536254 2
T28/2003 Turkey Istanbul Jackal 2003 AY536255 2
T29/2003 Turkey Istanbul Jackal 2003 AY536256 2
T30/2003 Turkey Istanbul Jackal 2003 AY536257 2
T31/2003 Turkey Aydin Fox 2003 AY536258 2
93100TU Turkey – Dog 1993 U43014 12
93101TU Turkey – Dog 1992 U43015 12
T1 Turkey Sanlurfa Cow 2000 DQ837474 9
T2 Turkey Istanbul Dog 2000 DQ837475 9
T3 Turkey Istanbul Dog 2000 DQ837476 9
T4 Turkey Istanbul Dog 2000 DQ837477 9
T5 Turkey Istanbul Dog 2000 DQ837478 9
T6 Turkey Istanbul Dog 2000 DQ837479 9
T7 Turkey Istanbul Dog 2000 DQ837480 9
TR33 Turkey Kilis Human 2002 EU180616 This study
TR149 Turkey Agri Human 2004 EU180618 This study
TR3 Turkey Aydin Human 2006 EU180615 This study
TR40 Turkey Adana Human 2006 EU180617 This study
8681IRA Iran – Dog 1986 U22482 14
8702IRA Iran – Wolf 1987 U22483 14
8706ARS SaudiArabia – Red Fox 1987 U22481 14
RV308 Georgia Cow – AY352497 10
SL9655 Lebanon – Stone Marten 1997 DQ837465 11
J1 Jordan Amman Goat 1999 DQ837422 11
J2 Jordan Karak Donkey 1999 DQ837423 11
J3 Jordan Irbid Cow 1998 DQ837424 11
J5 Jordan Ajloun Squirrel 1998 DQ8374226 11
Am4828 Israel Aramsha Cow 2004 DQ837390 11
329 Israel Golan Heights Human 1996 DQ837383 11
Vs3370 Israel Salama Fox 1995 DQ837484 11
Ah8437 Israel Ahihud Cow 2005 DQ837387 11
Ab2437 Israel Avihail Fox 2004 DQ837385 11
Hb1064 Israel Hebron Donkey 2002 DQ837414 11
Ih5700 Israel Iahel Fox 1997 DQ837419 11
Gr9489 Israel Groﬁt Fox 1998 DQ837411 11
Nk5630 Israel Neot Hakikar Fox 2000 DQ837450 11
Mg1353 Israel Merom Golan Cow 1997 DQ837441 11
Od6220 Israel Odem Wolf 2005 DQ837454 11
Ar8606 Israel Elrom Badger 2005 DQ837932 11
Nt1211 Israel Natur Cow 2004 DQ837453 11
Od9613 Israel Odem Dog 2005 DQ837455 11
Ek0187 Israel Ein Kinya Dog 2005 DQ837408 11
Az0298 Israel Ein Zivan Dog 2005 DQ837393 11
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Abstract
We describe a patient with conﬁrmed novel H1N1 (swine-like)
inﬂuenza A virus who had daily nasal swabs tested during oseltamivir
therapy. Nasal shedding remained positive for 2 days and became
negative on day 3. This report presents the ﬁrst available data on the
kinetics of shedding of this novel virus under antiviral therapy.
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